Healthcare Professionals

Our Medicines

Our Medicines
Xaggitin® XL (Methylphenidate hydrochloride) Bioequivalent to Concerta® XL*2 Writing a prescription for branded Xaggitin® XL saves the NHS between 39%-50% compared with writing a generic prescription for prolonged-release methylphenidate tablets3 Xaggitin XL is a prolonged-release form of methyphenidate, indicated as part of a comprehensive treatment programme for Attention Deficit Hyperactivity Disorder (ADHD) in children aged 6 years of age … Continue reading "Xaggitin® XL"
Zomorph® (morphine sulfate) Zormorph® is indicated in adults for the treatment of severe chronic pain and/or pain resistant to other analgesics, in particular associated with cancer.
Ipinnia® XL (Ropinirole prolonged release tablets) Ipinnia® XL is indicated in adults for the treatment of Parkinson's Disease
Pipexus® (Pramipexole) Pipexus® is indicated in adults for treatment of the signs and symptoms of idiopathic Parkinson’s disease
Ventra® (esomeprazole) Ventra® is indicated in the treatment of Gastro-oesophageal Reflux Disease (GORD):
Venlalic® XL (venlafaxine) Venlalic ® XL is indicated for the treatment of major depressive episodes.
Fencino® (fentanyl) Fencino ® is indicated for the long term management of severe chronic pain which can be adequately managed only with opioid analgesics.
Abtard® (oxycodone) Abtard ® is indicated for the treatment of severe pain, which can be adequately managed only with opioid analgesics.
uk-flag
About Ethypharm UK

Our Vision – To be chosen by the NHS as a trusted provider of quality, affordable medicines that deliver sustainable value

DB Ashbourne was acquired by Ethypharm SA in 2015 and is now part of the Ethypharm group

Report adverse events

Reporting forms and information
can be found at:
www.mhra.gov.uk/yellowcard

Adverse events should also be reported to Ethypharm UK Ltd

Healthcare professionals medical information

Any personal data you share with us will remain confidential at all times.

Medical enquiries can be directed to the Medical Information department using the form below:

WEB/UK/0002/16
  • Copyright - Ethypharm - 2016